bpc-157 human clinical trial pain Data: Promising, But Not Proven In Humans Early animal studies suggest BPC-157 may reduce behaviors in inflammatory and non-inflammatory models, including reduced allodynia. But this does not establish B12 Deficiency Emerging opportunities for nicotinamide Strength:5mg+5mg

bpc-157 human clinical trial pain Data: Promising, But Not Proven In Humans Early animal studies suggest BPC-157 may reduce behaviors in inflammatory and non-inflammatory models, including reduced allodynia. But this does not establish B12 Deficiency Emerging opportunities for nicotinamide Strength:5mg+5mg

Emerging opportunities for nicotinamide N-methyltransferase (NNMT) inhibitor clinical translation: Trends in Pharmacological Sciences

Supports Mood & Mental Health – NAD+ has been linked to higher serotonin levels, potentially improving mood, anxiety, and depression symptoms

B12 Deficiency

Strength:5mg+5mg

Simple timing framework Baseline Discuss baseline labs before starting, especially with diabetes risk, cancer history, edema, nerve symptoms, or active growth-related medical concerns